EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions

Charné Rossouw, Feargal J Ryan iD, David J Lynn iD

The FEBS Journal · 2025-03 · 292 (6) · 1480-1499

DOI: 10.1111/febs.17241 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 05.08.2024. Verfasst von Charné Rossouw und 2 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Vaccination, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antigen‐specific B and T cell responses play a critical role in vaccine‐mediated protection against infectious diseases, but these responses are highly variable between individuals and vaccine immunogenicity is frequently sub‐optimal in infants, the elderly and in people living in low‐ and middle‐income countries. Although many factors such as nutrition, age, sex, genetics, environmental exposures, and infections may all contribute to variable vaccine immunogenicity, mounting evidence indicates that the gut microbiota is an important and targetable factor shaping optimal immune responses to vaccination. In this review, we discuss evidence from human, preclinical and experimental studies supporting a role for a healthy gut microbiota in mediating optimal vaccine immunogenicity, including the immunogenicity of COVID‐19 vaccines. Furthermore, we provide an overview of the potential mechanisms through which this could occur and discuss strategies that could be used to target the microbiota to boost vaccine immunogenicity where it is currently sub‐optimal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeVaccinationCOVID-19 VaccinesCOVID-19Immunogenicity, VaccineHumansSARS-CoV-2AnimalsT-LymphocytesB-Lymphocytes

Stichwörter der Autor:innen

COVID‐19antibody responsesmicrobiomemicrobiotavaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Precision Medicine, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia.
  • Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.

ORCID-Profile: Feargal J Ryan, David J Lynn

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Rossouw, C., Ryan, F. J., & Lynn, D. J. (2025). The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions. The FEBS Journal, 292(6), 1480-1499. https://doi.org/10.1111/febs.17241

Vancouver

Rossouw C, Ryan FJ, Lynn DJ. The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions. The FEBS Journal. 2025;292(6):1480-1499. doi:10.1111/febs.17241

BibTeX
@article{Rossouw2025,
  author = {Rossouw, Charné and Ryan, Feargal J and Lynn, David J},
  title = {The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {6},
  pages = {1480--1499},
  doi = {10.1111/febs.17241}
}
Kostenlos starten →